DeutschNewstral
Article
Mmarketwatch.com on 2018-07-06 20:11
Zynerba stock rebounds after selloff driven by failed cannabis-based skin patch trial
Related news
- MZynerba shares slide 17% after trial of cannabis-based skin patch fails to meet goalsmarketwatch.com
- MEuropean stocks stage small rebound after trade-driven selloffmarketwatch.com
- MTreasury yields rebounds as stocks attempt to claw back from weeklong selloffmarketwatch.com
- MStocks rebound after huge tech-driven selloffmarketwatch.com
L'Oreal reveals smart skin patchBBC
A skin patch to treat peanut allergies? Study in toddlers shows promisetimesfreepress.com- MU.S. stocks poised to rise after Monday’s tech-driven selloffmarketwatch.com
- ISkin patch dissolves 'love handles' in miceinnovations-report.com
At the open: TSX steady; Wall Street rebounds from steep selloffThe Globe and Mail- MGold rebounds from Friday's selloff as precious metals rally2 min readmarketwatch.com
Peanut allergies: skin patch for toddlers shows promise in trialstheweek.co.uk
Skin patch seen helping young children with peanut allergiesThe Japan Times
Skin patch could be a safe treatment for peanut allergiesThe Daily Gazette
How a skin patch could help people with peanut allergiesbangordailynews.com
Study: Skin patch could help kids with peanut allergieswsfa.com
What is NuCalm? Is Meghan Markle's skin patch a scam?New York Post
Zynerba: Q2 Earnings Snapshotkansascity.com